Journal
LANCET DIABETES & ENDOCRINOLOGY
Volume 3, Issue 3, Pages 216-226Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S2213-8587(14)70142-1
Keywords
-
Categories
Funding
- Medical Research Council [G0802765, G0900567] Funding Source: researchfish
- MRC [G0900567] Funding Source: UKRI
- Medical Research Council [G0802765, G0900567] Funding Source: Medline
Ask authors/readers for more resources
Adrenal insufficiency continues to be a challenge for patients, their physicians, and researchers. During the past decade, long-term studies have shown increased mortality and morbidity and impaired quality of life in patients with adrenal insufficiency. These findings might, at least partially, be due to the failure of glucocorticoid replacement therapy to closely resemble physiological diurnal secretion of cortisol. The potential effect of newly developed glucocorticoid drugs is a focus of research, as are the mechanisms potentially underlying increased morbidity and mortality. Adrenal crisis remains a threat to lives, and awareness and preventative measures now receive increasing attention. Awareness should be raised in medical teams and patients about adrenal insufficiency and management of adrenal crisis to improve clinical outcome.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available